World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 8 January 2018
Main ID:  NCT03123562
Date of registration: 17/04/2017
Prospective Registration: No
Primary sponsor: Vinmec Research Institute of Stem Cell and Gene Technology
Public title: Improvement in Gross Motor Function and Muscle Tone in Children With Cerebral Palsy Related to Neonatal Icterus
Scientific title: Improvement in Gross Motor Function and Muscle Tone in Children With Cerebral Palsy Related to Neonatal Icterus: An Open-label, Uncontrolled Clinical Trial
Date of first enrolment: April 1, 2014
Target sample size: 25
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03123562
Study type:  Interventional
Study design:  Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  Phase 2
Countries of recruitment
Vietnam
Contacts
Name:     Liem T Nguyen, MD., PhD
Address: 
Telephone:
Email:
Affiliation:  Vinmec Research Institute of Stem Cell and Gene Technology
Key inclusion & exclusion criteria

Inclusion Criteria:

- Cerebral palsy of any types caused by neonatal icterus

Exclusion Criteria:

- Epilepsy

- Hydrocephalus with ventricular drain

- Coagulation disorders

- Allergy to anesthetic agents

- Severe health conditions such as cancer, failure of heart, lung, liver or kidney

- Active infections



Age minimum: 1 Year
Age maximum: 15 Years
Gender: All
Health Condition(s) or Problem(s) studied
Cerebral Palsy
Intervention(s)
Combination Product: Stem cell transplantation
Primary Outcome(s)
GMFM-88 and GMFM-66 Percentile [Time Frame: Time Frame: Baseline and 6 months after transplantation]
Secondary Outcome(s)
Change in Muscle tone [Time Frame: Time Frame: Baseline and 6 months after transplantation]
Number of adverse events [Time Frame: Through study completion, an average of 6 months]
Secondary ID(s)
VinmecRISCGT68
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history